In addition to blocking HOTAIR, drugs could be developed that directly target molecules in the HOTAIR pathway listed in Table 3, Table 4, Table 5 and Table 6, such as ERs in BC, SUZ12 in CRC, and VEGF/MMP-9 in HCC. Here, MMP9 is linked to colorectal carcinoma.